Therapy for fibrotic diseases: nearing the starting line.

@article{Friedman2013TherapyFF,
  title={Therapy for fibrotic diseases: nearing the starting line.},
  author={Scott L Friedman and Dean Sheppard and Jeremy S. Duffield and Shelia M. Violette},
  journal={Science translational medicine},
  year={2013},
  volume={5 167},
  pages={167sr1}
}
Fibrosis, or the accumulation of extracellular matrix molecules that make up scar tissue, is a common feature of chronic tissue injury. Pulmonary fibrosis, renal fibrosis, and hepatic cirrhosis are among the more common fibrotic diseases, which in aggregate represent a huge unmet clinical need. New appreciation of the common features of fibrosis that are conserved among tissues has led to a clearer understanding of how epithelial injury provokes dysregulation of cell differentiation, signaling… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 182 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 227 references

The role of the pericyte

  • C. Schrimpf, J. S. Duffield, Mechanisms of fibrosis
  • Curr. Opin. Nephrol. Hypertens. 20, 297–305
  • 2011
Highly Influential
5 Excerpts

The integrin avb6 binds and activates latent TGF b1

  • J. S. Munger, X. Huang, +11 authors fibrosis
  • Cell 96, 319–328
  • 1999
Highly Influential
6 Excerpts

Regulators and effectors of immunity and tissue remodeling

  • H. Spits, J. P. Di Santo, The expanding family of innate lymphoid cells
  • Nat. Immunol. 12, 21–27
  • 2011
Highly Influential
9 Excerpts

Similar Papers

Loading similar papers…